Cell Biology

Q.-w. Xie, H.J. Cho, J. Calaycay, et al., "Cloning and characterization of inducible nitric oxide synthase from mouse macrophages," Science, 256:225-8, 1992. Carl Nathan (Division of Hematology-Oncology, Cornell University Medical College, New York): "In 1992, Science touted nitric oxide (NO) as `the molecule of the year.' Many articles contributed to this sobriquet. Among them, the most frequently cited has been this paper, produced in a collaboration with Merck Sharpe & Dohme Research Labor

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Q.-w. Xie, H.J. Cho, J. Calaycay, et al., "Cloning and characterization of inducible nitric oxide synthase from mouse macrophages," Science, 256:225-8, 1992.

Carl Nathan (Division of Hematology-Oncology, Cornell University Medical College, New York): "In 1992, Science touted nitric oxide (NO) as `the molecule of the year.' Many articles contributed to this sobriquet. Among them, the most frequently cited has been this paper, produced in a collaboration with Merck Sharpe & Dohme Research Laboratories, Rahway, N.J., and the Beckman Research Institute of the City of Hope, Duarte, Calif.

"The impact of this study was twofold. First, it clearly established that there is more than one form of NO synthase (NOS), since the inducible enzyme from cytotoxic macrophages (iNOS) differed extensively from the constitutive isoform in the nervous system. The evidence was definitive, consisting of not only the cDNA sequence but also the amino acid sequence of the macrophage protein determined from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies